免疫系统的目标是阻止未来的SARS-CoV-2变种
Milena Silva Souza1,2, Jéssica Pires Farias1, Wilson Barros Luiz2
1Western Bahia Virology Institute, Center of Biological Sciences and Health, Federal University of Western Bahia , Barreiras, Bahia, Brazil.
Microbiology spectrum
|November 15, 2023
概括
科学家们确定了SARS-CoV-2尖端蛋白的保护区域,为未来的疫苗提供了潜在的目标,以对抗像Omicron这样的新兴变体.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- SARS-CoV-2 (严重急性呼吸系统综合征冠状病毒2) 的出现导致了全球大流行.
- 快速的科学合作导致了COVID-19疫苗的开发.
- 病毒遗传变异对疫苗有效性构成威胁.
研究的目的:
- 在SARS-CoV-2尖端蛋白中识别保存的抗原区域.
- 评估这些地区在不同变异的关注和野生类型病毒的保护情况.
- 为广泛的抗病毒策略提出潜在的目标.
主要方法:
- 对尖端蛋白序列的生物信息分析.
- 跨SARS-CoV-2变种 (阿尔法,贝塔,玛,三角形,奥米克朗) 和野生型的抗原区域的比较.
- 识别高度保存的表征物.
主要成果:
- 在尖端蛋白中发现了高度保存的抗原区域.
- 这些受保护的区域存在于所有令人担忧的变种和野生型病毒中.
- 这些发现突出了下一代疫苗的潜在目标.
结论:
- 在SARS-CoV-2尖端蛋白中保存的抗原区域代表了未来疫苗开发的有希望的目标.
- 针对这些保护区域可以提供更广泛的保护,防止当前和未来的SARS-CoV-2变种.
- 这项研究有助于开发针对冠状病毒的更强大,更持久的免疫策略.
相关概念视频
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35


